Healthcare-Associated Atypical Pneumonia

ABSTRACT

Atypical pneumonia was first described in 1938, and over time, Mycoplasma, Legionella, and Chlamydophila were the agents commonly linked with community-associated atypical pneumonia. However, as technology has improved, so has our understanding of this clinical entity. It is now known that there are many agents linked with atypical pneumonia in the community, and many of these agents are also major causes of healthcare-associated pneumonia. This article discusses the history, epidemiology, and pathogenesis of infection; control of infection; clinical findings; diagnosis; and, where applicable, treatment of the agents of healthcare-associated atypical pneumonia. Bacterial agents include Legionella species, Mycoplasma pneumoniae, Chlamydophila species, and Coxiella burnetii. Although there are over 100 viruses that can cause respiratory tract infections, only a fraction of those have been defined in the context of healthcare-associated atypical pneumonia: adenovirus and human bocavirus (HBoV); rhinovirus; human coronaviruses (HCoV), including HCoV 229E, HCoV OC43, HCoV NL63, HCoV HKU1; members of the paramyxoviridae (parainfluenza viruses, human metapneumovirus, and respiratory syncytial virus); hantavirus; influenza; and severe acute respiratory syndrome (SARS) Co-V. Our knowledge about healthcare-associated atypical pneumonia will continue to evolve as newer pathogens are identified and as newer diagnostic modalities such as multiplex polymerase chain reaction are introduced.

Atypical pneumonia - legionnaires disease - SARS - viral - Coxiella burnetii

REFERENCES

• 1 Reimann H A. An acute infection of the respiratory tract with atypical pneumonia.  JAMA. 1938;  111 2377-2384
• 2 Fraser D W, Tsai T R, Orenstein W and the Field Investigation Team et al.. Legionnaires' disease: description of an epidemic of pneumonia.  N Engl J Med. 1977;  297 1189-1197
• 3 Tsai T F, Finn D R, Plikaytis B D, McCauley W, Martin S M, Fraser D W. Legionnaires' disease: clinical features of the epidemic in Philadelphia.  Ann Intern Med. 1979;  90 509-517
• 4 McDade J E, Shepard C C, Fraser D W, Tsai T R, Redus M A, Dowdle W R. and the Laboratory Investigation Team . Legionnaires' disease: isolation of a bacterium and demonstration of its role in other respiratory diseases.  N Engl J Med. 1977;  297 1197-1203
• 5 Meyer R D. Legionella infections: a review of five years of research.  Rev Infect Dis. 1983;  5 258-278
• 6 Joseph C A. Legionnaires' disease in Europe 2000 – 2002.  Epidemiol Infect. 2004;  132 417-424
• 7 Boccia S, Laurenti P, Borella P et al.. Prospective 3-year surveillance for nosocomial and environmental Legionella pneumophila: implications for infection control.  Infect Control Hosp Epidemiol. 2006;  27 459-465
• 8 Marrie T J, MacDonald S, Clarke K, Haldane D. Nosocomial Legionnaires' disease: lessons from a four year prospective study.  Am J Infect Control. 1991;  19 79-85
• 9 Benin A L, Benson R F, Besser R E. Trends in legionnaires disease, 1990–1998: declining mortality and new patterns of diagnosis.  Clin Infect Dis. 2002;  35 1039-1046
• 10 Fields B S, Benson R F, Besser R E. Legionella and legionnaires' disease: 25 years of investigation.  Clin Microbiol Rev. 2002;  15 506-526
• 11 Yu V L. Nosocomial legionellosis.  Curr Opin Infect Dis. 2000;  13 385-388
• 12 Parry M F, Stampkman L, Hutchinson J H, Folta D, Steinberg M G, Krasnogor L J. Waterborne Legionella bozemanii and nosocomial pneumonia in immunosuppressed patients.  Ann Intern Med. 1985;  103 205-210
• 13 Tang P W, Toma S, MacMillan L G. Legionella oakridgensis: laboratory diagnosis of a human infection.  J Clin Microbiol. 1985;  21 462-463
• 14 Marrie T J, Haldane D, Bezanson G, Peppard R. Each water outlet is a unique ecological niche for Legionella pneumophila .  Epidemiol Infect. 1992;  108 261-270
• 15 Marrie T J, Haldane D, MacDonald S et al.. Control of endemic nosocomial legionnaires' disease by using sterile potable water for high risk patients.  Epidemiol Infect. 1991;  107 591-605
• 16 Bezanson G, Burbridge S, Haldane D, Yoell C, Marrie T. Diverse populations of Legionella pneumophila present in water of geographically clustered institutions served by the same water reservoir.  J Clin Microbiol. 1992;  30 570-576
• 17 Bezanson G, Fernandez R, Haldane D, Burbridge S, Marrie T. Virulence of patient and water isolates of Legionella pneumophila in guinea pigs and mouse L929 cells varies with bacterial genotype.  Can J Microbiol. 1994;  40 426-431
• 18 Bezanson G, Burbridge S, Haldane D, Marrie T. In situ colonization of polyvinyl chloride, brass and copper by Legionella pneumophila .  Can J Microbiol. 1992;  38 328-330
• 19 Plouffe J F, Para M F, Mathea W E, Hackman B, Webster L. Subtypes of Legionella pneumophila serogroup 1 associated with different attack rates.  Lancet. 1983;  2 649-650
• 20 Plouffe J F, Webster L R, Hackman B. Relationships between colonization of hospital buildings with Legionella pneumophila and hot water temperatures.  Appl Environmental Microbiol. 1983;  46 769-770
• 21 O'Neill E, Humphreys H. Surveillance of hospital water and primary prevention of nosocomial legionellosis: what is the evidence?.  J Hosp Infect. 2005;  59 273-279
• 22 Allegheny County Health Department .Approaches to Prevention and Control of Legionella Infection in Allegheny County Health Care Facilities. 2nd ed. Pittsburgh, PA; Allegheny County Health Department 1977: 1-15
• 23 Gorman G W, Yu V L, Brown A et al.. Isolation of Pittsburgh pneumonia agent from nebulizers used in respiratory therapy.  Ann Intern Med. 1980;  93 572-573
• 24 Jones E, Checko P, Dalton A et al.. Nosocomial legionnaires' disease associated with exposure to respiratory therapy equipment, Connecticut. In: Thornsberry C, Feeley JC Proceedings of the Second International Symposium on Legionella . American Society for Microbiology, Washington, DC 1984: 225-226
• 25 Kaan J A, Simoons-Smit A M, MacLaren D M. Another source of aerosol causing nosocomial legionnaires' disease.  J Infect. 1985;  11 145-148
• 26 Hanrahan J P, Morse D L, Scharf V B et al.. Community hospital legionellosis outbreak linked to hot water showers: transmission by potable hot water.  Am J Epidemiol. 1987;  125 639-649
• 27 Cordes L G, Wiesenthal A M, Gorman G W et al.. Isolation of Legionella pneumophila from hospital shower heads.  Ann Intern Med. 1981;  94 195-197
• 28 Garbe P L, Davis B J, Weisfeld J S et al.. Nosocomial legionnaires' disease: epidemiologic demonstration of cooling towers as a source.  JAMA. 1985;  254 521-524
• 29 Levy P Y, Teysseire N, Etienne J, Raoult D. A nosocomial outbreak of Legionella pneumophila caused by contaminated transesophageal probes.  Infect Control Hosp Epidemiol. 2003;  24 619-622
• 30 Modol J, Sabria M, Reynaga E et al.. Hospital-acquired legionnaires disease in a university hospital: impact of the copper–silver ionization system.  Clin Infect Dis. 2007;  44 263-265
• 31 Tablan O C, Anderson L J, Besser R, Bridges C, Hajjeh R. CDC; Healthcare Infection Control Practices Advisory Committee . Guidelines for preventing health care associated pneumonia. 2003.  MMWR Recomm Rep. 2004;  53(RR-3) 1-36
• 32 Marrie T J, Haldane D, Bezanson G. Nosocomial Legionnaires' disease: clinical and radiographic patterns.  Can J Infect Dis. 1992;  3 253-260
• 33 Rudin J E, Wing E J. A comparative study of Legionella micdadei and other nosocomially acquired pneumonia.  Chest. 1984;  86 675-680
• 34 Kirby B D, Snyder K M, Meyer R D, Finegold S M. Legionnaires disease: report of 65 nosocomially acquired cases and review of the literature.  Medicine. 1980;  59 188-205
• 35 Sanders K L, Walker D H, Lee T J. Relapse of legionnaires disease in a renal transplant recipient.  Arch Intern Med. 1980;  140 833-834
• 36 Marrie T J, Johnson W M, Tyler S D, Bezanson G S, Burbridge S. Genomic stability of Legionella pneumophila isolates recovered from two cardiac transplant patients with nosocomial legionnaires' disease.  J Clin Microbiol. 1994;  32 3085-3087
• 37 Waterer G W, Baselski V S, Wunderink R G. Legionella and community-acquired pneumonia: a review of current diagnostic tests from a clinician's viewpoint.  Am J Med. 2001;  110 41-48
• 38 Den Boer J W, Yzerman E PF. Diagnosis of Legionella infection in legionnaires' disease.  Eur J Clin Microbiol Infect Dis. 2004;  23 871-878
• 39 Plouffe J F, File Jr T M, Breiman R F et al.. Reevaluation of the definition of legionnaires disease: use of the urinary antigen assay. Community Based Pneumonia Incidence Study Group.  Clin Infect Dis. 1995;  20 1286-1291
• 40 Plouffe J F, Breiman R F, Fields B S et al.. Azithromycin in the treatment of Legionella pneumonia requiring hospitalization.  Clin Infect Dis. 2003;  37 1475-1480
• 41 Yu V L, Greenberg R N, Zadeikis N et al.. Levofloxacin efficacy in the treatment of community-acquired legionellosis.  Chest. 2004;  125 2135-2139
• 42 Yu V L, Zuravleff J J, Gavlik L, Magnussen M H. Lack of evidence for person-to-person transmission of legionnaires' disease.  J Infect Dis. 1983;  147 362
• 43 Marrie T J, George J, MacDonald S, Haase D. Are health care workers at risk for infection during an outbreak of nosocomial legionnaires' disease?.  Am J Infect Control. 1986;  14 209-213
• 44 Chanock R M. Mycoplasma infections of man.  N Engl J Med. 1965;  273 1199-1206, 1257–1264
• 45 Foy H M, Kenny G E, Mc Mahan A M, Grayston J T. Mycoplasma pneumoniae pneumonia in an urban area. Five years of surveillance.  JAMA. 1970;  214 1666-1672
• 46 Foy H M, Kenny G E, Cooney M K, Allan I D. Long-term epidemiology of infections with Mycoplasma pneumoniae. .  J Infect Dis. 1979;  139 681-687
• 47 Balassanian N, Robbins F C. Mycoplasma pneumoniae infection in families.  N Engl J Med. 1967;  277 719-725
• 48 Kleemola M, Jokinen C. Mycoplasma pneumoniae infection among hospital personnel studied by nucleic acid hybridization test.  J Hosp Infect. 1992;  21 213-221
• 49 Louie M, Dyck B, Parker S et al.. Nosocomial pneumonia in a Canadian tertiary care center: a prospective surveillance study.  Infect Control Hosp Epidemiol. 1991;  12 356-363
• 50 Goldwater P N, Martin A J, Ryan B et al.. A survey of nosocomial respiratory viral infections in a children's hospital: occult respiratory infections in patients admitted during an epidemic season.  Infect Control Hosp Epidemiol. 1991;  12 231-238
• 51 Casalta J P, Piquet P, Alazia M, Guidon-Attalia C, Drancourt M, Raoult D. Mycoplasma pneumoniae pneumonia following assisted ventilation.  Am J Med. 1996;  101 165-169
• 52 Fisher B, Yu B, Armstrong D, Magill J. Outbreak of Mycoplasma pneumoniae infection amongst hospital personnel.  Am J Med Sci. 1978;  276 205-209
• 53 Schachter J, Stamm W E. Chlamydia. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH Manual of Clinical Microbiology. 7th ed. Washington, DC; American Society of Microbiology 1999: 795-806
• 54 Troy C J, Peeling R W, Ellis A G et al.. Chlamydia pneumoniae as a new source of infectious outbreaks in nursing homes.  JAMA. 1997;  277 1214-1218
• 55 Grayston J T, Kuo C-C, Wang S-P, Altman J. A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections.  N Engl J Med. 1986;  315 161-168
• 56 Nakashima K, Tanaka T, Kramer M H et al.. Outbreak of Chlamydia pneumonia infection in a Japanese nursing home, 1999–2000.  Infect Control Hosp Epidemiol. 2006;  27 1171-1177
• 57 Strausbaugh L J, Sukumar S, Joseph C L. Infectious disease outbreaks in nursing homes: an unappreciated hazard for frail elderly persons.  Clin Infect Dis. 2003;  36 870-876
• 58 Loeb M, McGeer A, McArthur M, Peeling R W, Petric M, Simor A E. Surveillance for outbreaks of respiratory tract infections in nursing homes.  CMAJ. 2000;  162 1133-1137
• 59 Hughes C, Maharg P, Rosario P et al.. Possible nosocomial transmission of psittacosis.  Infect Control Hosp Epidemiol. 1997;  18 165-168
• 60 Heddema E R, van Hanner E J, Duim B et al.. An outbreak of psittacosis due to Chlamydophila psittaci genotype A in a veterinary teaching hospital.  J Med Microbiol. 2006;  55(Pt11) 1571-1575
• 61 Marrie T J, Raoult D. Update on Q fever, including Q fever endocarditis. Current Clinical Topics in Infectious Diseases. Edited by Jack S. Remington, Morton N. Swartz Malden, MA; Blackwell Publishing 2002 22: 97-124
• 62 Harman J B. Q fever in Great Britain; clinical account of eight cases.  Lancet. 1949;  2 1028-1030
• 63 Gerth H-J, Leidig U, Reimenschneider T H. Q-fieber-epidemie in einem Institut fur Humanpathologie.  Dtsch Med Wochenschr. 1982;  107 1391-1395
• 64 Deutch D L, Peterson E T. Q fever: transmission from one human being to others.  JAMA. 1950;  143 348-350
• 65 Raoult D, Stein A. Q fever during pregnancy: a risk factor for women, fetuses and obstetricians [letter].  N Engl J Med. 1994;  330 371
• 66 Osorio S, Sarria C, Gonzalez-Ruano P, Casal C, Garcia A. Nosocomial transmission of Q fever.  J Hosp Infect. 2003;  54 162-163
• 67 Schachter J, Sung M, Meyer K F. Potential danger of Q fever in a university environment.  J Infect Dis. 1971;  123 301-304
• 68 Meiklejohn G, Reimer L G, Graves P S, Helmick C. Cryptic epidemic of Q fever in a medical school.  J Infect Dis. 1981;  144 107-114
• 69 Hall C J, Richmond S J, Caul E O, Pearce N H, Silver I A. Laboratory outbreak of Q fever acquired from sheep.  Lancet. 1982;  1 1004-1006
• 70 Curet L B, Paust J C. Transmission of Q fever from experimental sheep to laboratory personnel.  Am J Obstet Gynecol. 1972;  114 566-568
• 71 National Association of State Public Health Veterinarians, Inc. (NASPHV); Centers for Disease Control and Prevention (CDC); Council of State and Territorial Epidemiologists; American Veterinary Medical Association . Compendium of measures to prevent disease associated with animals in public settings, 2007.  MMWR Recomm Rep. 2007;  56(RR-5) 1-14
• 72 Bernard K W, Parham G L, Winkler W G, Helmick C G. Q fever control measures: recommendations for research facilities using sheep.  Infect Control. 1982;  3 461-465
• 73 Perry S, Dennie C J, Coblentz C L, Cleland S. Minimizing the risk of Q fever in the hospital setting.  Can J Infect Control. 1994;  9 5-8
• 74 Duchin J S, Koster F T, Peters C J et al.. Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease.  N Engl J Med. 1994;  330 949-955
• 75 Peters C J, Khan A S. Hantavirus pulmonary syndrome: the new American hemorrhagic fever.  Clin Infect Dis. 2002;  34 1224-1231
• 76 Mills J N, Corneil A, Young J C, Garrison L E, Khan A S, Ksiazek T G. Hantavirus pulmonary syndrome—United States updated recommendations for risk reduction.  MMWR Recomm Rep. 2002;  51(RR-9) 1-12
• 77 Lazaro M E, Cantoni G E, Calanni L M et al.. Clusters of hantavirus infection, Southern Argentina.  Emerg Infect Dis. 2007;  13 104-110
• 78 Ferres M, Vial P, Marco C et al.. Prospective evaluation of household contacts of persons with hantavirus cardiopulmonary syndrome in Chile.  J Infect Dis. 2007;  195 1563-1571
• 79 Couch R B, Englund J A, Whimbey E. Respiratory viral infections in immunocompetent and immunocompromised persons.  Am J Med. 1997;  102(3A) 2-9
• 80 Templeton K E, Scheltinga S A, van den Eeden W C, Graffelman A W, van den Broek P J, Claas E C. Improved diagnosis of the etiology of community-acquired pneumonia with real-time polymerase chain reaction.  Clin Infect Dis. 2005;  41 345-351
• 81 Allander T, Andreasson K, Gupta S et al.. Identification of a third human polyomavirus.  J Virol. 2007;  81 4130-4136
• 82 Gaynor A M, Nissen M D, Whiley D M et al.. Identification of a novel polyomavirus from patients with acute respiratory tract infections.  PLoS Pathog. 2007;  3 e64
• 83 Raad I, Abbas J, Whimbey E. Infection control of nosocomial respiratory viral disease in the immunocompromised host.  Am J Med. 1997;  102(3A) 48-52
• 84 Nichols W G, Peck Campbell A J, Boeckh M. Respiratory viruses other than influenza virus: impact and therapeutic advances.  Clin Microbiol Rev. 2008;  21 274-290
• 85 Rosen L. A hemagglutination-inhibitor technique for typing adenoviruses.  Am J Hyg. 1960;  71 120-128
• 86 Buescher E L. Respiratory disease and the adenoviruses.  Med Clin North Am. 1967;  51 769-779
• 87 Gray G C, Goswami P R, Malasig M D et al.. Adult adenovirus infections: loss of orphaned vaccines precipitates military disease epidemics.  Clin Infect Dis. 2000;  31 663-670
• 88 Centers for Disease Control and Prevention (CDC) . Two fatal cases of adenovirus-related illness in previously healthy young adults—Illinois, 2000.  MMWR Morb Mortal Wkly Rep. 2001;  50 553-555
• 89 Yamadera S, Yamashita K, Akatsuka M, Kato N, Inouye S. Trend of adenovirus type 7 infection, an emerging disease in Japan: a report of the national epidemiological surveillance of infectious agents in Japan.  Jpn J Med Sci Biol. 1998;  51 43-51
• 90 Klinger J R, Sanchez M P, Curtin L A, Durkin M, Matyas B. Multiple cases of life threatening adenovirus pneumonia in a mental health care center.  Am J Respir Crit Care Med. 1998;  157 645-649
• 91 Centers for Disease Control and Prevention (CDC) . Acute respiratory disease associated with adenovirus serotype 14—four states, 2006–2007.  MMWR Morb Mortal Wkly Rep. 2007;  56 1181-1184
• 92 Palomino M A, Larranaga C, Avendano L F. Hospital-acquired adenovirus 7th infantile respiratory infection in Chile.  Pediatr Infect Dis J. 2000;  19 527-531
• 93 Hatherill M, Levin M, Lawrenson J, Hsiao N Y, Reynolds L, Argent A. Evolution of an adenovirus outbreak in a multidisciplinary children's hospital.  J Paediatr Child Health. 2004;  40 449-454
• 94 Levandowski R A, Rubenis M. Nosocomial conjunctivitis caused by adenovirus type 4.  J Infect Dis. 1981;  143 28-31
• 95 James L, Vernon M O, Jones R C et al.. Outbreak of human adenovirus type 3 infection in a pediatric long-term care facility—Illinois, 2005.  Clin Infect Dis. 2007;  45 416-420
• 96 Singh-Naz N, Brown M, Ganeshananthan M. Nosocomial adenovirus infection: molecular epidemiology of an outbreak.  Pediatr Infect Dis J. 1993;  12 922-925
• 97 Larranaga C, Martinez J, Palomino A, Pena M, Carrion F, Avendano L F. Molecular characterization of hospital-acquired adenovirus infantile respiratory infection in Chile using species-specific PCR assays.  J Clin Virol. 2007;  39 175-181
• 98 Abad F X, Pinto R M, Bosch A. Survival of enteric viruses on environmental fomites.  Appl Environ Microbiol. 1994;  60 3704-3710
• 99 Nwachuku N, Gerba C P, Oswald A, Mashadi F D. Comparative inactivation of adenovirus serotypes by UV light disinfection.  Appl Environ Microbiol. 2005;  71 5633-5636
• 100 Takeuchi R, Nomura M, Kojima M, Uchio E, Kobayashi N, Matumoto M. A nosocomial outbreak of epidemic keratoconjunctivitis due to adenovirus type 37.  Microbiol Immunol. 1990;  34 749-754
• 101 Aitken C, Jeffries D J. Nosocomial spread of viral disease.  Clin Microbiol Rev. 2001;  14 528-546
• 102 American Academy of Pediatrics . Adenovirus infections. In: Pickering LK, Baker CJ, Long SS, McMillan JA Red Book: 2006 Report of the Committee on Infectious Diseases. 27th ed. Elk Grove Village, IL; American Academy of Pediatrics 2006: 202-204
• 103 Allander T, Tammi M T, Eriksson M et al.. Cloning of a human parvovirus by molecular screening of respiratory tract samples.  Proc Natl Acad Sci U S A. 2005;  102 12891-12896
• 104 Kesebir D, Vazquez M, Weibel C et al.. Human bocavirus infection in young children in the United States: molecular epidemiology profile and clinical characteristics of a newly emerging respiratory virus.  J Infect Dis. 2006;  194 1276-1282
• 105 Kleines M, Scheithauer S, Rackowitz A, Ritter K, Hausler M. High prevalence of human bocavirus detected in young children with severe acute lower respiratory tract disease by use of a standard PCR protocol and a novel real-time PCR protocol.  J Clin Microbiol. 2007;  45 1032-1034
• 106 Bastien N, Brandt K, Dust K, Ward D, Li Y. Human bocavirus infection, Canada.  Emerg Infect Dis. 2006;  12 848-850
• 107 Kantola K, Hedman L, Allander T et al.. Serodiagnosis of human bocavirus infection.  Clin Infect Dis. 2008;  46 540-546
• 108 Allander T. Human bocavirus.  J Clin Virol. 2008;  41 29-33
• 109 Schildgen O, Muller A, Allander T et al.. Human bocavirus: passenger of pathogen in acute respiratory tract infections?.  Clin Microbiol Rev. 2008;  21 291-304
• 110 Papadopoulos N G, Hunter J, Sanderson G, Johnston S L. Rhinovirus identification by Bgl I digestion of picornavirus amplicons.  J Virol Methods. 1999;  80 179-185
• 111 Ghosh S, Champlin R, Couch R et al.. Rhinovirus infections in myelosuppressed adult bone and marrow transplant recipients.  Clin Infect Dis. 1999;  29 528-532
• 112 Wald T G, Shult P, Krause P, Miller B A, Drinka P, Gravenstein S. A rhinovirus outbreak among residents of a long-term care facility.  Ann Intern Med. 1995;  123 588-593
• 113 Hendley J O, Gwaltney Jr J M. Mechanisms of transmission of rhinovirus infections.  Epidemiol Rev. 1988;  10 243-258
• 114 Kaiser L, Hayden F G. Rhinovirus pneumonia: a clinical entity?.  Clin Infect Dis. 1999;  29 533-535
• 115 Wenzel R P, Hendley J O, Davies J A, Gwaltney Jr J M. Coronavirus infections in military recruits: three year study with coronavirus strains OC43 and 229E.  Am Rev Respir Dis. 1974;  109 621-624
• 116 McIntosh K, Chao R K, Krause H E, Wasil R, Mocega H E, Mufson M A. Coronavirus infection in acute lower respiratory tract disease of infants.  J Infect Dis. 1974;  130 502-507
• 117 Ksiazek T G, Erdman D, Goldsmith C S and the SARS Working Group et al.. A novel coronavirus associated with severe acute respiratory syndrome.  N Engl J Med. 2003;  348 1953-1966
• 118 van der Hoek L, Pyrc K, Jebbink M F et al.. Identification of a new human coronavirus.  Nat Med. 2004;  10 368-373
• 119 Fouchier R A, Hartwig N G, Bestebroer T M et al.. A previously undescribed coronavirus associated with respiratory disease in humans.  Proc Natl Acad Sci U S A. 2004;  101 6212-6216
• 120 Esper F, Weibel C, Ferguson D, Landry M L, Kahn J. Evidence of a novel human coronavirus that is associated with respiratory tract disease in infants and young children.  J Infect Dis. 2005;  191 492-498
• 121 Kahn J S. The widening scope of coronaviruses.  Curr Opin Pediatr. 2006;  18 42-47
• 122 Woo P C, Lau S K, Huang Y, Tsoi H W, Chan K H, Yuen K Y. Phylogenetic and recombination analysis of coronavirus HKU1, a novel coronavirus from patients with pneumonia.  Arch Virol. 2005;  150 2299-2311
• 123 Woo P C, Lau S K, Tsoi H W et al.. Clinical and molecular epidemiological features of coronavirus HKU1-associated community-acquired pneumonia.  J Infect Dis. 2005;  192 1898-1907
• 124 Kuypers J, Martin E T, Heugel J, Wright N, Morrow R, Englund J A. Clinical disease in children associated with newly described coronavirus subtypes.  Pediatrics. 2007;  119 e70-e76
• 125 Clarke S KR. Parainfluenza virus infections.  Postgrad Med J. 1973;  49 792-797
• 126 Clarke S KR. Parainfluenza virus infections.  Postgrad Med J. 1973;  49 792-797
• 127 Wendt C H, Weisdorf D J, Jordan M C, Balfour Jr H H, Hertz M I. Parainfluenza virus respiratory infection after bone marrow transplantation.  N Engl J Med. 1992;  326 921-926
• 128 Lewis V A, Champlin R, Englund J et al.. Respiratory disease due to parainfluenza virus in adult bone marrow transplant recipients.  Clin Infect Dis. 1996;  23 1033-1037
• 129 Whimbey E, Vartivarian S E, Champlin R E, Elting L S, Luna M, Bodey G P. Parainfluenza virus infection in adult bone marrow transplant recipients.  Eur J Clin Microbiol Infect Dis. 1993;  12 699-701
• 130 Lau S KP, To W, Tse P WT et al.. Human parainfluenza virus 4 outbreak and the role of diagnostic tests.  J Clin Microbiol. 2005;  43 4515-4521
• 131 Cortez K J, Erdman D D, Peret T C et al.. Outbreak of human parainfluenza virus 3 infection in a hematopoietic stem cell transplant population.  J Infect Dis. 2001;  184 1093-1097
• 132 Fiore A E, Iverson C, Messmer T et al.. Outbreak of pneumonia in a long-term care facility: antecedent parainfluenza virus type 1 infection may predispose to bacterial pneumonia.  J Am Geriatr Soc. 1998;  46 1112-1117
• 133 Zambon M, Bull T, Sadler C J, Goldman J M, Ward K N. Molecular epidemiology of two consecutive outbreaks of parainfluenza 3 in a bone marrow transplant unit.  J Clin Microbiol. 1998;  36 2289-2293
• 134 Jalal H, Bibby D F, Bennett J et al.. Molecular investigation of an outbreak of parainfluenza virus type 3 and respiratory syncytial virus infections in a hematology unit.  J Clin Microbiol. 2007;  45 1690-1696
• 135 Nichols W G, Erdman D D, Han A, Zukerman C, Corey L, Boeckh M. Prolonged outbreak of human parainfluenza virus 3 infection in a stem cell transplant outpatient department: insights from molecular epidemiologic analysis.  Biol Blood Marrow Transplant. 2004;  10 58-64
• 136 Brady M T, Evans J, Cuartas J. Survival and disinfection of parainfluenza viruses on environmental surfaces.  Am J Infect Control. 1990;  18 18-23
• 137 Van den Hoogen B G, de Jong J C, Groen J et al.. A newly discovered human pneumovirus isolated from young children with respiratory tract disease.  Nat Med. 2001;  7 719-724
• 138 Crowe Jr J E. Human metapneumovirus as a major cause of human respiratory tract disease.  Pediatr Infect Dis J. 2004;  23 S215-S221
• 139 Falsey A R, Erdman D, Anderson L J et al.. Human metapneumovirus infections in young and elderly adults.  J Infect Dis. 2003;  187 785-790
• 140 Hamelin M E, Cote S, Laforge J et al.. Human metapneumovirus infection in adults with community acquired pneumonia and exacerbation of chronic obstructive pulmonary disease.  Clin Infect Dis. 2005;  41 498-502
• 141 O'Gorman C, McHenry E, Coyle P V. Human metapneumovirus in adults: a short case series.  Eur J Clin Microbiol Infect Dis. 2006;  25 190-192
• 142 Stockton J, Stephenson I, Fleming D, Zambon M. Human metapneumovirus as a cause of community acquired respiratory illness.  Emerg Infect Dis. 2002;  8 897-901
• 143 Boivin G, Abed Y, Pelletier G et al.. Virological features and clinical manifestations associated with human metapneumovirus: a new paramyxovirus responsible for acute respiratory tract infections in all age groups.  J Infect Dis. 2002;  186 1330-1334
• 144 Boivin G, De Serres G, Hamelin M et al.. An outbreak of severe respiratory tract infection due to human metapneumovirus in a long-term care facility.  Clin Infect Dis. 2007;  44 1152-1158
• 145 Johnstone J, Majumdar S R, Fox J D, Marrie T J. Presentation of human metapneumovirus in adults: results from a prospective study.  Clin Infect Dis. 2008;  46 571-574
• 146 Chano F, Rousseau C, Laferrier C, Couillard M, Charest H. Epidemiological survey of human metapneumovirus in a large pediatric tertiary care center.  J Clin Microbiol. 2005;  43 5520-5525
• 147 Cheng V CC, Wu A KL, Cheung C HY et al.. Outbreak of human metapneumovirus infection in psychiatric inpatients: implications for directly observed use of alcohol handrub in prevention of nosocomial outbreaks.  J Hosp Infect. 2007;  67 336-343
• 148 Evashuk K M, Forgie S E, Gilmour S, Huynh H, Lee B E, Robinson J L. Respiratory failure associated with human metapneumovirus infection in an infant posthepatic transplant.  Am J Transplant. 2008;  8 1567-1569
• 149 Adams J. Primary virus pneumonitis with cytoplasmic inclusion bodies: a study of an epidemic involving thirty-two infants with nine deaths.  JAMA. 1941;  116 925-933
• 150 Morris J A, Blount Jr R E, Savage R E. Recovery of cytopathogenic agent from chimpanzees with coryza.  Proc Soc Exp Biol Med. 1956;  92 544-549
• 151 Chanock R, Roizman B, Myers R. Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA). I. Isolation, properties and characterization.  Am J Hyg. 1957;  66 281-290
• 152 Adams J M, Imagawa D T, Zike K. Epidemic bronchiolitis and pneumonia related to respiratory syncytial virus.  JAMA. 1961;  176 1037-1039
• 153 Black C P. Systematic review of the biology and medical management of respiratory syncytial virus infection.  Respir Care. 2003;  48 209-233
• 154 Hall C B. Nosocomial respiratory syncytial virus infections.  N Engl J Med. 1975;  293 1343-1346
• 155 Hall C B. The nosocomial spread of respiratory syncytial virus infections.  Annu Rev Med. 1983;  34 311-319
• 156 Langley J M, LeBlanc J C, Wang E E et al.. Nosocomial respiratory syncytial virus infection in Canadian pediatric hospitals: a pediatric investigators collaborative network on infections in Canada study.  Pediatrics. 1997;  100 943-946
• 157 Hall C B, Kopelman A, Douglas R J. Neonatal respiratory syncytial virus infections.  N Engl J Med. 1979;  300 393-396
• 158 Forster J, Schumacher R. The clinical picture presented by premature neonates infected with the respiratory syncytial virus.  Eur J Pediatr. 1995;  154 901-905
• 159 Falsey A R, McCann R M, Hall W J et al.. Acute respiratory tract infection in daycare centers for older persons.  J Am Geriatr Soc. 1995;  43 30-36
• 160 Osterweil D, Norman D. An outbreak of an influenza-like illness in a nursing home.  J Am Geriatr Soc. 1990;  38 659-662
• 161 Sorvillo F J, Huie S F, Strassburg M A, Butsumyo A, Shandera W X, Fannin S L. An outbreak of respiratory syncytial virus pneumonia in a nursing home for the elderly.  J Infect. 1984;  9 252-256
• 162 Falsey A R, Cunningham C K, Barker W H et al.. Respiratory syncytial virus and influenza A infections in the hospitalized elderly.  J Infect Dis. 1995;  172 389-394
• 163 Falsey A R, Treanor J J, Betts R F, Walsh E E. Viral respiratory infections in the institutionalized elderly: clinical and epidemiologic findings.  J Am Geriatr Soc. 1992;  40 115-119
• 164 Hall W J, Hall C B, Speers D M. Respiratory syncytial virus infections in adults: clinical, virologic, and serial pulmonary function studies.  Ann Intern Med. 1978;  88 203-205
• 165 Hall C B, Geiman J M, Biggar R, Kotok D I, Hogan P M, Douglas Jr R G. Respiratory syncytial virus infections within families.  N Engl J Med. 1976;  294 414-419
• 166 Falsey A R, Hennessey R N, Formica M A et al.. Respiratory syncytial virus infection in elderly and high risk adults.  N Engl J Med. 2005;  352 1749-1759
• 167 Hall C B, Douglas Jr R G. Modes of transmission of respiratory syncytial virus.  J Pediatr. 1981;  99 100-103
• 168 Hall C B, Douglas Jr R G, Schnabel K C, Geiman J M. Infectivity of respiratory syncytial virus by various routes of inoculation.  Infect Immun. 1981;  33 779-783
• 169 Hall C B. Nosocomial respiratory syncytial virus infections: the “Cold War” has not ended.  Clin Infect Dis. 2000;  31 590-596
• 170 Hall C B, Geiman J M, Douglas Jr R G, Meagher M P. Control of nosocomial respiratory syncytial viral infections.  Pediatrics. 1978;  62 728-732
• 171 Hall C B, Walsh E E, Long C E, Schnabel K C. Immunity to and frequency of reinfection with respiratory syncytial virus.  J Infect Dis. 1991;  163 693-698
• 172 Henderson F W, Collier A M, Clyde Jr W A, Denny F W. Respiratory-syncytial-virus infections, reinfections and immunity: a prospective, longitudinal study in young children.  N Engl J Med. 1979;  300 530-534
• 173 Hall C B, Douglas Jr R G, Geiman J M. Respiratory syncytial virus infections in infants: quantitation and duration of shedding.  J Pediatr. 1976;  89 11-15
• 174 Hall C B, Powell K R, MacDonald N E et al.. Respiratory syncytial viral infection in children with compromised immune function.  N Engl J Med. 1986;  315 77-80
• 175 Hall C B, Douglas Jr R G, Geiman J M. Possible transmission by fomites of respiratory syncytial virus.  J Infect Dis. 1980;  141 98-102
• 176 Karanfil L V, Conlon M, Lykens K et al.. Reducing the rate of nosocomially transmitted respiratory syncytial virus.  Am J Infect Control. 1999;  27 91-96
• 177 Snydman D R, Greer C, Meissner H C, McIntosh K. Prevention of nosocomial transmission of respiratory syncytial virus in a newborn nursery.  Infect Control Hosp Epidemiol. 1988;  9 105-108
• 178 Krasinski K, LaCouture R, Holzman R S, Waithe E, Bonk S, Hanna B. Screening for respiratory syncytial virus and assignment to a cohort at admission to reduce nosocomial transmission.  J Pediatr. 1990;  116 894-898
• 179 Rotter M L. Hand washing and hand disinfection. In: Mayhall CG Hospital Epidemiology and Infection Control. 2nd ed. Philadelphia; Lippincott, Williams & Wilkins 1999: 1339-1355
• 180 Pittet D, Mouraga P, Pernegar T V et al.. Compliance with hand hygiene in a teaching hospital.  Ann Intern Med. 1999;  130 126-129
• 181 Hugonnet S, Perneger T V, Pittet D. Alcohol-based handrub improves compliance with hand hygiene in intensive care units.  Arch Intern Med. 2002;  162 1037-1043
• 182 Harbarth S, Pittet D, Grady L et al.. Interventional study to evaluate the impact of an alcohol-based hand gel in improving hand hygiene compliance.  Pediatr Infect Dis J. 2002;  21 489-495
• 183 Hall C B, Douglas Jr R G, Geiman J M. Possible transmission by fomites of respiratory syncytial virus.  J Infect Dis. 1980;  141 98-102
• 184 Davis P J, Spady D, Forgie S E. A survey of Alberta physicians' use of and attitudes toward face masks and face shields in the operating room setting.  Am J Infect Control. 2007;  35 455-459
• 185 Alcasid G, Garcia-Houchins S, Peev M, Marcinak J, Weber S G. Failure to Institute appropriate isolation precautions for suspected respiratory syncytial virus (RSV) infection: frequency and identification of risk factors.  Am J Infect Control. 1994;  32 E1
• 186 Sehulster L, Chinn R Y. Centers for Disease Control and Prevention, HICPAC . Guidelines for environmental infection control in healthcare facilities: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC).  MMWR Recomm Rep. 2003;  52(RR-10) 1-42
• 187 Couch R B, Kasel J A, Glezen W P et al.. Influenza: its control in persons and populations.  J Infect Dis. 1986;  153 431-440
• 188 Connolly A M, Salmon R L, Williams D H. What are the complications of influenza and can they be prevented? Experience from the 1989 epidemic of H 3 N2 influenza A in general practice.  BMJ. 1993;  306 1452-1454
• 189 Schoch-Spana M. Implications of pandemic influenza for bioterrorism response.  Clin Infect Dis. 2000;  31 1409-1413
• 190 Lui K-J, Kendal A P. Impact of influenza epidemics on mortality in the United States from October 1972 to May 1985.  Am J Public Health. 1987;  77 712-716
• 191 Monto A S, Kioumehr F. Tecumseh study of respiratory illness, IX: Occurrence of influenza in the community, 1966–1971.  Am J Epidemiol. 1975;  102 553-563
• 192 Cox N J, Fukuda K. Influenza.  Infect Dis Clin North Am. 1998;  12 27-38
• 193 Cate T R. Viral pneumonia due to influenza and parainfluenza viruses and adenoviruses. In: Marrie TJ Community-Acquired Pneumonia. New York; Kluwer Academic/Plenum 2001: 593-616
• 194 Bridges C B, Fukuda K, Cox N J, Singleton J A. Advisory Committee on Immunization Practices . Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP).  MMWR Recomm Rep. 2001;  50(RR-4) 1-44
• 195 Kaiser L, Hayden F G. Hospitalizing influenza in adults.  Curr Clin Top Infect Dis. 1999;  19 112-134
• 196 Public Heath Agency of Canada .Pandemic Influenza Plan. http://www.phac-aspc.gc.ca/cpip-pclcpi/index.html
• 197 Webster R G, Peiris M, Chen H, Guan Y. H5N1 outbreaks and enzootic influenza.  Emerg Infect Dis. 2006;  12 3-8
• 198 World Health Organization .Cumulative number of confirmed cases of Avian Influenza A/(H5N1) reported to WHO. Available at: http://www.who.int/csr/disease/avian_influenza/country/cases_table__2007__07_02_03/en/index.html
• 199 Simor A E. Influenza outbreaks in long-term care facilities: how can we do better?.  Infect Control Hosp Epidemiol. 2002;  23 564-567
• 200 Pachucki C T, Walsh Pappas S A, Fuller G F, Krause S L, Lentino J R, Schaaf D M. Influenza A among hospital personnel and patients.  Arch Intern Med. 1989;  149 77-80
• 201 Horcajada J P, Pumarola T, Martinez J et al.. A nosocomial outbreak of influenza during a period without influenza epidemic activity.  Eur Respir J. 2003;  21 303-307
• 202 World Health Organization Writing Group . Non-pharmaceutical interventions for pandemic influenza, national and community measures.  Emerg Infect Dis. 2006;  12 88-94
• 203 Sokol D K. Virulent epidemics and scope of healthcare workers' duty of care.  Emerg Infect Dis. 2006;  12 1238-1241
• 204 Starr I. Influenza in 1918: recollections of the epidemic in Philadelphia.  Ann Intern Med. 2006;  145 138-140
• 205 Low D. microbiologist-in-chief, Mount Sinai Hospital, Toronto, Canada .Personal communication. 
• 206 Holmberg S D, Layton C M, Ghneim G S, Wagenert D K. State plans for containment of pandemic influenza.  Emerg Infect Dis. 2006;  12 1414-1417
• 207 Mounier-Jack S, Coker R J. How prepared is Europe for pandemic influenza? Analysis of national plans.  Lancet. 2006;  367 1405-1411
• 208 Brankston G, Gitterman L, Hirji Z, Lemieux C, Gardam M. Transmission of influenza in human beings.  Lancet Infect Dis. 2007;  7 257-265
• 209 Buxton-Bridges C, Kuehnert M J, Hall C B. Transmission of influenza. implications for control in health care settings.  Clin Infect Dis. 2003;  37 1094-1101
• 210 Riley R L. Airborne infection.  Am J Med. 1974;  57 466-475
• 211 Goldrock LR, Liverman CT Preparing for an influenza pandemic: personal protective equipment for healthcare workers. 2007 Available at: http://www.nap.edu/catalog/11980.html
• 212 Hui D SC, Sung J JY. Severe acute respiratory syndrome.  Chest. 2003;  124 12-15
• 213 Feng Y, Gao G F. Towards our understanding of SARS-CoV an emerging and devastating but quickly conquered virus.  Comp Immunol Microbiol Infect Dis. 2007;  30 309-327
• 214 Kuiken T, Fouchier R AM, Schutten M et al.. Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome.  Lancet. 2003;  362 263-270
• 215 Wang L-F, Shi Z, Zhang S, Field H, Daszak P, Eaton B T. Review of bats and SARS.  Emerg Infect Dis. 2006;  12 1834-1840
• 216 Gu J, Korteweg C. Pathology and pathogenesis of severe acute respiratory syndrome.  Am J Pathol. 2007;  170 1136-1147
• 217 Peiris J S, Yuen K Y, Osterhaus A D, Stohr K. The severe acute respiratory syndrome.  N Engl J Med. 2003;  349 2431-2441
• 218 Yu I T, Li Y, Wong T W et al.. Evidence of airborne transmission of severe acute respiratory syndrome virus.  N Engl J Med. 2004;  350 1731-1739
• 219 Wenzel R P, Bearman G, Edmond M B. Lessons from severe acute respiratory distress syndrome (SARS): implications for infection control.  Arch Med Res. 2005;  36 610-616
• 220 Olsen S J, Chang H-L, Cheung T-Y et al.. Transmission of severe acute respiratory syndrome on aircraft.  N Engl J Med. 2003;  349 2416-2422
• 221 Yu I T, Xie Z H, Tsoi K K et al.. Why did outbreaks of severe acute respiratory syndrome occur in some hospital wards but not in others?.  Clin Infect Dis. 2007;  44 1017-1025
• 222 Christian M D, Loutly M, McDonald L C et al.. Possible SARS coronavirus transmission during cardiopulmonary resuscitation.  Emerg Infect Dis. 2004;  10 287-293
• 223 Chen M I, Chow A L, Earnest A, Leong H N, Leo Y S. Clinical and epidemiological predictors of transmission is severe acute respiratory syndrome (SARS).  BMC Infect Dis. 2006;  6 151
• 224 Cai Q-C, Lu J, Xu Q-F et al.. Influence of meteorological factors and air pollution on the outbreak of acute respiratory syndrome.  Public Health. 2007;  121 258-265
• 225 Goh D L, Lee B W, Chia K S et al.. Secondary household transmission of SARS, Singapore.  Emerg Infect Dis. 2004;  10 232-234
• 226 Rea E, LaFleche J L, Stalker S et al.. Duration and distance of exposure are important predictors of transmission among community contacts of Ontario SARS cases.  Epidemiol Infect. 2007;  135 914-921
• 227 Rainer T H, Lee N, Ip M et al.. Features discriminating SARS from other severe viral respiratory tract infections.  Eur J Clin Microbiol Infect Dis. 2007;  26 121-129
• 228 Muller M, Tomlinson G, Marrie T J et al.. Can routine laboratory tests discriminate between severe acute respiratory syndrome and other causes of community-acquired pneumonia?.  Clin Infect Dis. 2005;  40 1079-1086
• 229 Ovens H, Thompson J, Lyver M, Murray M J, Innes G. Implications of the SARS outbreak for Canadian emergency departments.  CJEM. 2003;  5 343-347
• 230 Campbell A. The SARS Commission Report. Available at: http://www.sarscommission.ca/report/index.html Accessed May 21, 2008
• 231 Lee A M, Wong J GWS, McAlonan G M et al.. Stress and psychological distress among SARS survivors one year after the outbreak.  Can J Psychiatry. 2007;  52 233-240
• 232 Tansey C M, Louie M, Loeb M et al.. One year outcomes and health care utilization in survivors of severe acute respiratory syndrome.  Arch Intern Med. 2007;  167 1312-1320
• 233 Hwang S W, Cheung A M, Moineddin R, Bell C M. Population mortality during the outbreak of severe acute respiratory syndrome in Toronto.  BMC Public Health. 2007;  7 93